Sporos Biodiscovery Pipeline
| Drug | Indication | Phase |
|---|
| SPR1 | Cancers with Hippo-driver mutations/aberrations & YAP/TAZ hyperactivation | IND Enabling |
| SPR2 | Cancers resistant to immunotherapy | Discovery in Vitro |
| SPR3 | Cancers resistant to MAPK inhibition and/or immunotherapy | Discovery in Vitro |
| SPR4 | PTEN-deficient cancers | Discovery in Vitro |